The Denver Post

A mammal with the munchies: curing animals with cannabis

- By Rachel Nuwer

Like many captive elephants, Nidia had chronic foot problems. Fissures had formed in the 55-yearold Asian elephant’s foot pads, and her toenails had cracked and become ingrown. Painful abscesses lingered for months. Nidia had lost her appetite, and she was losing weight.

Dr. Quetzalli Hernández, the veterinari­an in charge of Nidia’s care at a wildlife park in Mexico, was desperate. She decided to try cannabidio­l, or CBD, the nonintoxic­ating therapeuti­c compound found in cannabis.

For help, Hernández reached out to Dr. Mish Castillo, chief veterinary officer at ICAN Vets, a company engaging in veterinary cannabis education and research in Mexico. To Castillo’s knowledge, no one had purposely given an elephant medical cannabis. But he and his colleagues hoped it would reduce Nidia’s pain and stimulate her appetite, as they had seen the drug do for cats, dogs and other species.

They started low and eventually settled on a dose of 0.02 milligrams of CBD per pound of Nidia’s weight, which she took daily with a chunk of fruit. Calibrated by weight, the dose is one-tenth to onefortiet­h of what Castillo gives to dogs or cats. Yet, it worked.

The first sign that the treatment was effective was when Nidia developed a serious case of the munchies. Within days of starting CBD, she went from finishing just one-third of her food to virtually all of it, and sometimes even went for seconds. Within five weeks, she had gained 555 pounds.

After Nidia began eating, her demeanor changed. “She was always known as the grumpy one — she used to kick doors,” Castillo said.

“Within the first week to 10 days of her treatment, she started coming out of her enclosure quicker and was in less of a bad mood.”

Nidia’s abscesses also began to heal, probably as a result of CBD’S anti-inflammato­ry effects. For months, the pain in her feet had prevented the elephant from walking down a small hill to a drinking fountain in her enclosure, forcing her handlers to give her water in buckets and by hose. As her condition improved, she started to visit the fountain again. “She just continued to get better,” Castillo said. “We were amazed that this happened at such a low-response dose, which led us to want to get this informatio­n out before veterinari­ans start overdosing other species by using the dog or cat dose.” Correct dosing comes down to species-specific difference­s in metabolism and variabilit­y between individual­s, he added.

Medical cannabis for humans is legal and commonly used in a number of countries and U.S. states. But its adoption in veterinary practices has lagged behind human medicine. Dozens of scientific studies point to cannabis’ potential for treating seizures, pain, anxiety and fear, mostly in dogs. Mounting anecdotal evidence from countries such as Mexico, where veterinari­ans can legally administer the plant or its compounds, suggests benefits across a variety of other conditions in species as varied as parrots, turtles and hyenas.

But despite the promising findings, challenges abound for introducin­g cannabis into veterinary medicine: confusion about the law, lingering drug-related stigma, a lack of education and a dearth of peer-reviewed studies. In most countries, including the United States, prohibitiv­e or incomplete legislatio­n also hampers veterinari­ans’ abilities to study and use cannabis in their practices.

“People are very interested in alternativ­e therapies that work better” and have fewer side effects, said Dr. Stephanie Mcgrath, a veterinary neurologis­t at Colorado State University who studies medical cannabis and is on the scientific advisory board of Panacea Life Sciences, a CBD product manufactur­er. “We really should be funneling dollars to support research so we can get a better understand­ing of how we should be using this medication,” she added.

Laws in places such as California have begun to make way for veterinary cannabis. And a small but growing number of internatio­nal veterinari­ans have united to bring cannabis into mainstream veterinary medicine through education, research and activism.

“Our countries are all going at different paces for regulation and legalizati­on,” Castillo said. “But we can work as a worldwide network of veterinari­ans to further advancemen­ts together.”

Cannabis contains 100plus chemical compounds, but CBD and tetrahydro­cannabinol (THC) are the molecules whose therapeuti­c effects are best understood. While CBD does not discernibl­y alter consciousn­ess, THC is responsibl­e for the “high” associated with smoking or ingesting marijuana.

Across vertebrate species, these molecules interact with the endocannab­inoid system, a network of nerve receptors, molecules and enzymes that keeps the body’s other organ systems stable. When used medically, cannabis essentiall­y “supports the support system,” said Dr. Casara Andre, founder of Veterinary Cannabis, a Colorado-based group that provides education and certificat­ion to animal care workers and consultati­on services for pet owners and the cannabis industry.

A number of countries now legally permit veterinari­ans to prescribe and administer cannabis. In terms of research and adoption, though, Mexico is emerging as a world leader. Since 2019, Castillo and his colleagues have trained about 1,500 veterinari­ans in medical cannabis use.

Cannabis can be combined with convention­al pharmaceut­icals to improve those drugs’ results, veterinari­ans have found. And in some cases, given on its own, cannabis has outperform­ed existing drugs, said Emma Delaney, a pharmacist and sales manager at CBD Vets Australia, a company that provides education and medicinal cannabis to veterinari­ans in Australia.

Although things are moving slowly, Castillo said, each year brings more research findings, training courses and mentorship programs, as well as internatio­nal collaborat­ions.

Castillo and his colleagues, for example, are preparing to publish another case study about CBD use in a ferret named Macarena. The ferret fell from a fifth-floor balcony in 2017, causing severe spinal trauma and chronic pain. She was put on opioids, but persistent discomfort caused her to selfmutila­te. “She basically chewed her own back legs raw from the pain,” Castillo said.

Veterinari­ans amputated her back legs, but Macarena continued to show signs of distress, including by biting her abdomen.

Four years after her fall, Macarena found relief through CBD. At a dose of 0.3 milligrams of CBD per pound of her body weight, she stopped self-mutilating. She gained weight and became more active, Castillo and his colleagues said, and she was able to discontinu­e the use of opioids.

Macarena died in September from old age, and right up until her death, the researcher­s reported, she was in good spirits.

 ?? JAÍR COLL FOR THE NEW YORK TIMES ?? A perentie, a type of monitor lizard, receives cannabis oil for pain from a degenerati­ve joint disease at the Cali Zoo.
JAÍR COLL FOR THE NEW YORK TIMES A perentie, a type of monitor lizard, receives cannabis oil for pain from a degenerati­ve joint disease at the Cali Zoo.
 ?? JAÍR COLL FOR THE NEW YORK TIMES ?? Kanu, a Bengal tiger at the Cali Zoo in Colombia, received a bite of fish infused with cannabis oil to reduce inflammati­on and pain after having a cancerous tumor removed.
JAÍR COLL FOR THE NEW YORK TIMES Kanu, a Bengal tiger at the Cali Zoo in Colombia, received a bite of fish infused with cannabis oil to reduce inflammati­on and pain after having a cancerous tumor removed.

Newspapers in English

Newspapers from United States